Cargando…
Single versus Multiple Dose Ivermectin Regimen in Onchocerciasis-Infected Persons with Epilepsy Treated with Phenobarbital: A Randomized Clinical Trial in the Democratic Republic of Congo
Background: There is anecdotal evidence that ivermectin may decrease seizure frequency in Onchocerca volvulus-infected persons with epilepsy (PWE). Methods: In October 2017, a 12-month clinical trial was initiated in rural Democratic Republic of Congo. PWE with onchocerciasis-associated epilepsy exp...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157533/ https://www.ncbi.nlm.nih.gov/pubmed/32164367 http://dx.doi.org/10.3390/pathogens9030205 |
_version_ | 1783522364180398080 |
---|---|
author | Mandro, Michel Siewe Fodjo, Joseph Nelson Dusabimana, Alfred Mukendi, Deby Haesendonckx, Steven Lokonda, Richard Nakato, Swabra Nyisi, Francoise Abhafule, Germain Wonya’rossi, D Hotterbeekx, An Abrams, Steven Colebunders, Robert |
author_facet | Mandro, Michel Siewe Fodjo, Joseph Nelson Dusabimana, Alfred Mukendi, Deby Haesendonckx, Steven Lokonda, Richard Nakato, Swabra Nyisi, Francoise Abhafule, Germain Wonya’rossi, D Hotterbeekx, An Abrams, Steven Colebunders, Robert |
author_sort | Mandro, Michel |
collection | PubMed |
description | Background: There is anecdotal evidence that ivermectin may decrease seizure frequency in Onchocerca volvulus-infected persons with epilepsy (PWE). Methods: In October 2017, a 12-month clinical trial was initiated in rural Democratic Republic of Congo. PWE with onchocerciasis-associated epilepsy experiencing ≥2 seizures/month were randomly allocated to receive, over a one-year period, ivermectin once or thrice (group 1), while other onchocerciasis-infected PWE (OIPWE) were randomized to ivermectin twice or thrice (group 2). All participants also received anti-epileptic drugs. Data was analyzed using multiple logistic regression. Results: We enrolled 197 participants. In an intent-to-treat analysis (data from group 1 and 2 combined), seizure freedom was more likely among OIPWE treated with ivermectin thrice (OR: 5.087, 95% CI: 1.378–19.749; p = 0.018) and twice (OR: 2.471, 95% CI: 0.944–6.769; p = 0.075) than in those treated once. Similarly, >50% seizure reduction was more likely among those treated with ivermectin twice (OR: 4.469, 95% CI: 1.250–16.620) and thrice (OR: 2.693, 95% CI: 1.077–6.998). Absence of microfilariae during the last 4 months increased the odds of seizure freedom (p = 0.027). Conclusions: Increasing the number of ivermectin treatments was found to suppress both microfilarial density and seizure frequency in OIPWE, suggesting that O. volvulus infection plays an etiological role in causing seizures. |
format | Online Article Text |
id | pubmed-7157533 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-71575332020-05-01 Single versus Multiple Dose Ivermectin Regimen in Onchocerciasis-Infected Persons with Epilepsy Treated with Phenobarbital: A Randomized Clinical Trial in the Democratic Republic of Congo Mandro, Michel Siewe Fodjo, Joseph Nelson Dusabimana, Alfred Mukendi, Deby Haesendonckx, Steven Lokonda, Richard Nakato, Swabra Nyisi, Francoise Abhafule, Germain Wonya’rossi, D Hotterbeekx, An Abrams, Steven Colebunders, Robert Pathogens Article Background: There is anecdotal evidence that ivermectin may decrease seizure frequency in Onchocerca volvulus-infected persons with epilepsy (PWE). Methods: In October 2017, a 12-month clinical trial was initiated in rural Democratic Republic of Congo. PWE with onchocerciasis-associated epilepsy experiencing ≥2 seizures/month were randomly allocated to receive, over a one-year period, ivermectin once or thrice (group 1), while other onchocerciasis-infected PWE (OIPWE) were randomized to ivermectin twice or thrice (group 2). All participants also received anti-epileptic drugs. Data was analyzed using multiple logistic regression. Results: We enrolled 197 participants. In an intent-to-treat analysis (data from group 1 and 2 combined), seizure freedom was more likely among OIPWE treated with ivermectin thrice (OR: 5.087, 95% CI: 1.378–19.749; p = 0.018) and twice (OR: 2.471, 95% CI: 0.944–6.769; p = 0.075) than in those treated once. Similarly, >50% seizure reduction was more likely among those treated with ivermectin twice (OR: 4.469, 95% CI: 1.250–16.620) and thrice (OR: 2.693, 95% CI: 1.077–6.998). Absence of microfilariae during the last 4 months increased the odds of seizure freedom (p = 0.027). Conclusions: Increasing the number of ivermectin treatments was found to suppress both microfilarial density and seizure frequency in OIPWE, suggesting that O. volvulus infection plays an etiological role in causing seizures. MDPI 2020-03-10 /pmc/articles/PMC7157533/ /pubmed/32164367 http://dx.doi.org/10.3390/pathogens9030205 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Mandro, Michel Siewe Fodjo, Joseph Nelson Dusabimana, Alfred Mukendi, Deby Haesendonckx, Steven Lokonda, Richard Nakato, Swabra Nyisi, Francoise Abhafule, Germain Wonya’rossi, D Hotterbeekx, An Abrams, Steven Colebunders, Robert Single versus Multiple Dose Ivermectin Regimen in Onchocerciasis-Infected Persons with Epilepsy Treated with Phenobarbital: A Randomized Clinical Trial in the Democratic Republic of Congo |
title | Single versus Multiple Dose Ivermectin Regimen in Onchocerciasis-Infected Persons with Epilepsy Treated with Phenobarbital: A Randomized Clinical Trial in the Democratic Republic of Congo |
title_full | Single versus Multiple Dose Ivermectin Regimen in Onchocerciasis-Infected Persons with Epilepsy Treated with Phenobarbital: A Randomized Clinical Trial in the Democratic Republic of Congo |
title_fullStr | Single versus Multiple Dose Ivermectin Regimen in Onchocerciasis-Infected Persons with Epilepsy Treated with Phenobarbital: A Randomized Clinical Trial in the Democratic Republic of Congo |
title_full_unstemmed | Single versus Multiple Dose Ivermectin Regimen in Onchocerciasis-Infected Persons with Epilepsy Treated with Phenobarbital: A Randomized Clinical Trial in the Democratic Republic of Congo |
title_short | Single versus Multiple Dose Ivermectin Regimen in Onchocerciasis-Infected Persons with Epilepsy Treated with Phenobarbital: A Randomized Clinical Trial in the Democratic Republic of Congo |
title_sort | single versus multiple dose ivermectin regimen in onchocerciasis-infected persons with epilepsy treated with phenobarbital: a randomized clinical trial in the democratic republic of congo |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157533/ https://www.ncbi.nlm.nih.gov/pubmed/32164367 http://dx.doi.org/10.3390/pathogens9030205 |
work_keys_str_mv | AT mandromichel singleversusmultipledoseivermectinregimeninonchocerciasisinfectedpersonswithepilepsytreatedwithphenobarbitalarandomizedclinicaltrialinthedemocraticrepublicofcongo AT siewefodjojosephnelson singleversusmultipledoseivermectinregimeninonchocerciasisinfectedpersonswithepilepsytreatedwithphenobarbitalarandomizedclinicaltrialinthedemocraticrepublicofcongo AT dusabimanaalfred singleversusmultipledoseivermectinregimeninonchocerciasisinfectedpersonswithepilepsytreatedwithphenobarbitalarandomizedclinicaltrialinthedemocraticrepublicofcongo AT mukendideby singleversusmultipledoseivermectinregimeninonchocerciasisinfectedpersonswithepilepsytreatedwithphenobarbitalarandomizedclinicaltrialinthedemocraticrepublicofcongo AT haesendonckxsteven singleversusmultipledoseivermectinregimeninonchocerciasisinfectedpersonswithepilepsytreatedwithphenobarbitalarandomizedclinicaltrialinthedemocraticrepublicofcongo AT lokondarichard singleversusmultipledoseivermectinregimeninonchocerciasisinfectedpersonswithepilepsytreatedwithphenobarbitalarandomizedclinicaltrialinthedemocraticrepublicofcongo AT nakatoswabra singleversusmultipledoseivermectinregimeninonchocerciasisinfectedpersonswithepilepsytreatedwithphenobarbitalarandomizedclinicaltrialinthedemocraticrepublicofcongo AT nyisifrancoise singleversusmultipledoseivermectinregimeninonchocerciasisinfectedpersonswithepilepsytreatedwithphenobarbitalarandomizedclinicaltrialinthedemocraticrepublicofcongo AT abhafulegermain singleversusmultipledoseivermectinregimeninonchocerciasisinfectedpersonswithepilepsytreatedwithphenobarbitalarandomizedclinicaltrialinthedemocraticrepublicofcongo AT wonyarossid singleversusmultipledoseivermectinregimeninonchocerciasisinfectedpersonswithepilepsytreatedwithphenobarbitalarandomizedclinicaltrialinthedemocraticrepublicofcongo AT hotterbeekxan singleversusmultipledoseivermectinregimeninonchocerciasisinfectedpersonswithepilepsytreatedwithphenobarbitalarandomizedclinicaltrialinthedemocraticrepublicofcongo AT abramssteven singleversusmultipledoseivermectinregimeninonchocerciasisinfectedpersonswithepilepsytreatedwithphenobarbitalarandomizedclinicaltrialinthedemocraticrepublicofcongo AT colebundersrobert singleversusmultipledoseivermectinregimeninonchocerciasisinfectedpersonswithepilepsytreatedwithphenobarbitalarandomizedclinicaltrialinthedemocraticrepublicofcongo |